Th1-biased immune responses induced by DNA-based immunizations are mediated via action on professional antigen-presenting cells to up-regulate IL-12 production

Clinical and Experimental Immunology

Volumn 119, Issue 1, 2000, Pages 130-139

  Asakura, Y ^a   Liu, L J ^a   Shono, N ^a   Hinkula, J ^b   Kjerrstrom A ^b   Aoki, I ^c   Okuda, K ^a   Wahren, B ^b   Fukushima, J ^a  

^a Department of Bacteriology ^*  (Japan)

^b KAROLINSKA INSTITUTE   (Sweden)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

DNA based immunization; IL 12; Interferon ; Th1 biased immune responses professional antigen presenting cells

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 4; MESSENGER RNA; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PLASMID DNA; RECOMBINANT PROTEIN;

ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

EID: 0033979001     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01041.x     Document Type: Article

References (57)

1. 1 Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787-93.
2. 2 O'Garra A. Cytokines induce the development of functionally heterogenous T helper cell subsets. Immunity 1998; 8:275-83.
3. 3 Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4 T cells. Annu Rev Immunol 1994; 12:635-73.
4. 4 Demant P, Lipoldova M, Svobodova M. Resistance to Leishmania major in mice. Science 1996; 274:1392.
5. 5 Güler ML, Gorham JD, Hsieh C-S, Mackey AJ, Steen RG, Dietrich WF, Murphy KM. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 1996; 271:984-7.
6. 6 Noben-Trauth N, Kropf P, Müller I. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 1996; 271:987-90.
7. 7 Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995; 13:151-77.
8. 8 Swihart K, Fruth U, Messmer M et al. Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1 -type CD4+ T cell response. J Exp Med 1995; 181:961-71.
9. 9 Girard M, Kieny MP, Pinter A et al. Immunization of chimpanzees confer protection against challenge with human immunodeficiency virus. Proc Natl Acad Sci USA 1991; 88:542-6.
10. 10 Haynes BF. HIV vaccines: where we are and where we are going. Lancet 1996; 348:933-7.
11. 11 Calarota S, Bratt G, Nordlund S, Hinkula J, Leandersson AC, Sandstrom E, Wahren B. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 1998; 351: 1320-5.
12. 12 Huygen K, Content J, Denis O et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Med 1996; 2:893-8.
13. 13 Tascon RE, Colston MJ, Ragno S, Stavropoulos E, Gregory D, Lowrie DB. Vaccination against tuberculosis by DNA injection. Nature Med 1996; 2:888-92.
14. 14 Gerloni M, Ballou WR, Billetta R, Zanetti M. Immunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization. Nat Biotechnol 1997; 15:876-81.
15. 15 Boyer JD, Ugen KE, Wang B et al. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature Med 1997; 3:526-32.
16. 16 Donnelly JJ, Friedman A, Martinez D et al. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nature Med 1995; 1:583-7.
17. 17 Ulmer JB, Donnelly JJ, Parker SE et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259:1745-9.
18. 18 Choi AH, Knowlton DR, McNeal MM, Ward RL. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Virology 1997; 232:129-38.
19. 19 Lu S, Arthos J, Montefiori DC et al. Simian immunodeficiency virus DNA vaccine trial in macaques. J Virol 1996; 70:3978-91.
20. 20 Putkonen P, Quesada-Rolander M, Leandersson AC et al. Immune response but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts. Virology 1998; 250:293-301.
21. 21 Wahren B, Brytting M. DNA increases the potency of vaccination against infectious diseases. Curr Opin Chem Biol 1997; 1:183-9.
22. 22 Corr M, Lee DJ, Carson DA, Tighe H. Gene vaccination with naked plasmid DNA. Mechanism of CTL priming. J Exp Med 1996; 184:1555-60.
23. 23 Doe B, Selby M, Barnett S, Baenziger J, Walker CM. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci USA 1996; 93:8578-83.
24. 24 Chattergoon MA, Robinson TM, Boyer JD, Weiner DB. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophage/antigen-presenting cells. J Immunol 1998; 160:5708-18.
25. 25 Iwasaki A, Torres CA, Ohashi PS, Robinson HL, Barber BH. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol 1997; 159:11-4.
26. 26 Feltquate DM, Heaney S, Webster RG, Robinson HL. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 1997; 158:2278-84.
27. 27 Pertmer TM, Roberts TR, Haynes JR. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J Virol 1996; 70:6119-25.
28. 28 Krieg AM, Yi A-K, Matsson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374:546-9.
29. 29 Pisetsky DS. Immune activation by bacterial DNA. A new genetic code. Immunity 1996; 5:303-10.
30. 30 Sasaki S, Sumino K, Hamajima K et al. Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes. J Virol 1998; 72:4931-9.
31. 31 Tsuji T, Hamajima K, Fukushima J et al. Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J Immunol 1997; 158:4008-13.
32. 32 Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-γ. Annu Rev Immunol 1997; 15:749-95.
33. 33 Farrar MA, Schreiber RD. The molecular cell biology of interferon-γ and its receptor. Annu Rev Immunol 1993; 11:571-661.
34. 34 Karupiah G, Xie Q-W, Buller RML, Nathan C, Duarte C, MacMicking JD. Inhibition of viral replication by interferon-γ-induced nitrc oxide synthase. Science 1993; 261:1445-8.
35. 35 Müller U, Steinhoff U, Reis LFL, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. Functional role of type I and type II interferons in antiviral defence. Science 1994; 264:1918-21.
36. 36 Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 1993; 259:1739-42.
37. 37 Graham MB, Dalton DK, Giltinan D, Braciale VL, Stewart TA, Braciale TA. Response to influenza infection in mice with a target disruption in the interferon-γ gene. J Exp Med 1993; 178:1725-32.
38. 38 Huang S, Hendriks W, Althage A et al. Immune responses in mice that lack the interferon-γ receptor. Science 1993; 259:1742-5.
39. 39 Yang Y, Xiang Z, Ertl HC, Wilson JM. Upregulation of class I major histocompatibility complex antigens by interferon-gamma is necessary for T cell mediated elimination of recombinant adenovirus infected hepatocytes in vivo. Proc Natl Acad Sci USA 1995; 92:7257-61.
40. + cells through IL-12 produced by Listeria-induced macrophages. Science 1993; 260:547-9.
41. 41 Cullen BR. Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 1986; 46:973-82.
42. 42 Asakura Y, Hinkula J, Leandersson A-C, Fukushima J, Okuda K, Wahren B. Induction of HIV-1 specific mucosal immune responses by DNA vaccination. Scand J Immunol 1997; 46:326-30.
43. 43 Okuda K, Bukawa H, Hamajima K et al. Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products. AIDS Res Hum Retrovirus 1995; 11:933-43.
44. 2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype. J Immunol 1994; 153:1246-53.
45. 45 Murphy TL, Cleveland MG, Klesza P, Magram J, Murphy KM. Regulation of interleukin 12 p40 expression through NF-KB half-site. Mol Cell Biol 1995; 15:5258-67.
46. 46 Taki S, Sato T, Ogasawara K, Fukuda T et al. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 1997; 6:673-9.
47. 47 Hinkula J, Svanholm C, Schwartz S et al. Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type I regulatory genes. J Virol 1997; 71:5528-39.
48. 48 Lundholm P, Asakura Y, Hinkula J, Lucht E, Wahren B. Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA. Vaccine 1999; 17:2036-42.
49. 49 Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degradades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391:43-50.
50. 50 Takahashi H, Germain RN, Moss B, Berzofsky JA. An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself. J Exp Med 1990; 171:571-6.
51. 51 Asakura Y, Hamajima K, Fukushima J, Mohri H, Okubo T, Okuda K. Induction of HIV-1 Nef-specific cytotoxic T lymphocytes by Nef-expressing DNA vaccine. Am J Hematol 1996; 53:116-7.
52. 52 Asakura Y, Lundholm P, Kjerrström A et al. DNA-plasmids of HIV-1 induce systemic and mucosal immune responses. Biol Chem 1999; 380:375-9.
53. 53 Ulmer JB, Deck RR, Dewitt CM, Donnelly JJ, Liu MA. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells; antigen presentation by non-muscle cells. Immunology 1996; 89:59-67.
54. 54 Akira S, Okazaki K, Sakano H. Two pairs of recombination signals are sufficient to cause immunoglobulin V-(D)-J joining. Science 1987; 238:1134.
55. 55 Keene JA, Forman J. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med 1982; 155:768-82.
56. 56 Iwasaki A, Stiernholm BJ, Chan AK, Bernstein NL, Barber BH. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol 1997; 158:4591-601.
57. 57 Kim JJ, Ayyavoo V, Bagarazzi ML et al. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol 1997; 158:816-26.